China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Reinvestment Rate
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Reinvestment Rate of 0.11x as of December 2022, reinvesting $25.28K (capex $25.28K ) from operating cash flow of $234.18K. See SXTC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China SXT Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2020)
Historical reinvestment intensity for China SXT Pharmaceuticals Inc across 5 annual periods. For the full cash flow conversion analysis, see SXTC operating cash flow.
Annual Cash Flow Reinvestment Rate for China SXT Pharmaceuticals Inc (2016–2020)
Year-by-year capital reinvestment analysis for China SXT Pharmaceuticals Inc. See China SXT Pharmaceuticals Inc (SXTC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 6.32x | $5.90 Million | $934.25K | $406.66K | ▲ +23.9% |
| 2019 | 5.10x | $1.22 Million | $239.19K | $610.09K | ▲ +346.5% |
| 2018 | 1.14x | $2.19 Million | $1.92 Million | $1.05 Million | ▼ -91.1% |
| 2017 | 12.89x | $3.78 Million | $293.04K | $186.31K | ▲ +2324.4% |
| 2016 | 0.53x | $96.99K | $182.47K | $96.99K | — |